Excelsior Biopharma (6496) — Net Asset Quality Index
Excelsior Biopharma (6496) has a Net Asset Quality Index of 54.2% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of NT$1.48 Billion minus total liabilities of NT$679.78 Million yields net assets of NT$804.23 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read Excelsior Biopharma balance sheet liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Excelsior Biopharma Net Asset Quality Index Over Time (2017–2025)
This chart shows how Excelsior Biopharma's Net Asset Quality Index has evolved across 9 annual periods from 2017 to 2025. As of December 2025, the index stands at 54.2%, representing net assets of NT$804.23 Million against total assets of NT$1.48 Billion TWD. For live market cap and overall valuation, see Excelsior Biopharma (6496) market capitalisation.
Annual Net Asset Quality Index for Excelsior Biopharma (2017–2025)
The table below presents the year-by-year Net Asset Quality Index for Excelsior Biopharma from 2017 to 2025, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check 6496 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (TWD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 54.2% | NT$804.23 Million | NT$1.48 Billion | NT$679.78 Million | ▼ -8.6 pp |
| 2024 | 62.8% | NT$991.45 Million | NT$1.58 Billion | NT$586.89 Million | ▼ -7.2 pp |
| 2023 | 70.0% | NT$1.10 Billion | NT$1.58 Billion | NT$472.87 Million | ▼ -0.4 pp |
| 2022 | 70.4% | NT$1.21 Billion | NT$1.71 Billion | NT$507.53 Million | ▲ +3.5 pp |
| 2021 | 66.9% | NT$1.23 Billion | NT$1.84 Billion | NT$608.90 Million | ▼ -0.6 pp |
| 2020 | 67.5% | NT$1.28 Billion | NT$1.90 Billion | NT$617.15 Million | ▼ -16.2 pp |
| 2019 | 83.7% | NT$1.25 Billion | NT$1.50 Billion | NT$244.06 Million | ▲ +0.2 pp |
| 2018 | 83.5% | NT$1.37 Billion | NT$1.64 Billion | NT$270.88 Million | ▲ +3.7 pp |
| 2017 | 79.8% | NT$1.34 Billion | NT$1.68 Billion | NT$339.37 Million | — |